The last economic evaluation of pathogen reduction technology (PRT) in Canada was conducted in 2007. We reassessed the cost‐effectiveness of PRT in the province of Québec (which has its own… Click to show full abstract
The last economic evaluation of pathogen reduction technology (PRT) in Canada was conducted in 2007. We reassessed the cost‐effectiveness of PRT in the province of Québec (which has its own blood supplier) and included an evaluation of the potential impact of emerging pathogens on cost‐effectiveness.
               
Click one of the above tabs to view related content.